1 |
Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent renal damage after contrastinduced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation 2012;125:3099-107.
DOI
|
2 |
Rencuzogullari I, Cagdas M, Karakoyun S, et al. Association of Syntax score II with contrast-induced nephropathy and hemodialysis requirement in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J. 2017;48:59-70.
|
3 |
Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol 2017;6:86-99.
DOI
|
4 |
Liang M, Yang S, Fu N. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: a meta-analysis of 15 randomized controlled trials. Medicine (Baltimore) 2017;96:e7384.
DOI
|
5 |
Yun KH, Lim JH, Hwang KB, et al. Effect of high dose rosuvastatin loading before percutaneous coronary intervention on contrast-induced nephropathy. Korean Circ J 2014;44:301-6.
DOI
|